News
LVCLF
0.0064
NaN%
--
Weekly Report: what happened at LVCLF last week (0602-0606)?
Weekly Report · 6d ago
Algorae Pharmaceuticals Secures A$318,771 R&D Tax Rebate to Boost AI-Driven Drug Discovery
TipRanks · 06/05 23:48
Weekly Report: what happened at LVCLF last week (0526-0530)?
Weekly Report · 06/02 09:57
Weekly Report: what happened at LVCLF last week (0519-0523)?
Weekly Report · 05/26 09:56
Weekly Report: what happened at LVCLF last week (0512-0516)?
Weekly Report · 05/19 09:53
Weekly Report: what happened at LVCLF last week (0505-0509)?
Weekly Report · 05/12 09:53
Weekly Report: what happened at LVCLF last week (0428-0502)?
Weekly Report · 05/05 09:53
Algorae Pharmaceuticals Advances AI Drug Discovery and Strengthens Market Position
TipRanks · 04/29 00:28
Weekly Report: what happened at LVCLF last week (0421-0425)?
Weekly Report · 04/28 09:58
Weekly Report: what happened at LVCLF last week (0414-0418)?
Weekly Report · 04/21 09:57
Weekly Report: what happened at LVCLF last week (0407-0411)?
Weekly Report · 04/14 09:53
Weekly Report: what happened at LVCLF last week (0331-0404)?
Weekly Report · 04/07 09:53
Weekly Report: what happened at LVCLF last week (0324-0328)?
Weekly Report · 03/31 09:58
Algorae Pharmaceuticals Secures A$451,359 R&D Rebate to Boost AI-Driven Drug Development
TipRanks · 03/30 23:17
Weekly Report: what happened at LVCLF last week (0317-0321)?
Weekly Report · 03/24 09:53
Weekly Report: what happened at LVCLF last week (0310-0314)?
Weekly Report · 03/17 09:57
Weekly Report: what happened at LVCLF last week (0303-0307)?
Weekly Report · 03/10 09:58
Weekly Report: what happened at LVCLF last week (0224-0228)?
Weekly Report · 03/03 09:57
Algorae Pharmaceuticals Reports Reduced Losses and Advances AI Drug Discovery
TipRanks · 02/26 08:38
Weekly Report: what happened at LVCLF last week (0217-0221)?
Weekly Report · 02/24 09:58
More
Webull provides a variety of real-time LVCLF stock news. You can receive the latest news about Algorae Pharmaceuticals through multiple platforms. This information may help you make smarter investment decisions.
About LVCLF
Algorae Pharmaceuticals Limited is an Australia-based artificial-intelligence (AI) enabled drug discovery and development company. The Company is actively engaged in expanding its therapeutic pipeline using a proprietary artificial intelligence (AI) drug discovery and development platform, known as Algorae Operating System (AlgoraeOS). The AI platform leverages extensive medical and scientific databases from various disciplines within an advanced system at the intersection of AI and pharmaceutical research. By employing machine learning, deep learning, and neural networks, the AlgoraeOS is focused on uncovering synergistic fixed dose drug combinations that lead to the development of effective treatments for any medical condition. It is also focused on advancing its drug candidates, which include AI-116 for the treatment of neurodegenerative disorders and/or dementia, and AI-168 for cardiovascular disease and NTCELL for Parkinson’s disease.